The guidance is the latest in a series generated by NICE covering the use of digital health technologies to relieve pressure on the NHS, with earlier recommendations covering digital weight-loss ...

The main pharmacological interventions for palliation of breathlessness would be opioids, ie, oromorph and benzodiazepines ...

Home NICE Guidance Conditions and diseases Respiratory conditions Asthma Artificial intelligence-based technologies to aid lung function measurement for the diagnosis of suspected lung conditions: ...

You can now review and comment on this draft guideline. The consultation closes on Tuesday 08 July 2025 at 5pm. In line with NICE’s commitment to incorporate technology appraisals (TAs) within ...

This is a summary of the recommendations of the joint guideline on Asthma: diagnosis, monitoring and chronic asthma management, which was published in November 2024. This new collaborative guideline ...

Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively ...

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

Many individuals with chronic obstructive pulmonary disease describe exacerbations in personal, varied terms, revealing a ...

The decision follows NICE’s review of safety and efficacy data, including clinical and economic analyses showing that PFA ...

A recent national study revealed ongoing symptom burden and communication gaps in COPD care, and provided physicians with actionable improvement strategies.

COPD patients who receive intensive guidance from a hospital pharmacist during their stay use their inhalation medication more correctly and with greater confidence. This was shown in a study ...

The ACG has published new health maintenance recommendations for patients with IBD, which include appropriate vaccinations, ...